Skip to main content
Signal8
Launch Terminal

Regen BioPharma Inc (RGBP)

Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Regen BioPharma, Inc. logo

Regen BioPharma, Inc.

OTC:RGBPHealthcare
$0.0001
Mkt Cap$218K
Float1.58B
O/S1.68B
Inst Own-
SI<0.1%
Dilution
Regen BioPharma, Inc. logoOTC:RGBP$0.0001
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$217,786
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership0.00%

based on 1.68B shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryUSUS
IPO DateOct 6, 2014
Shares Outstanding1.68B
Float1.58B
Company Overview

Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States.

It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions.

Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.

Leadership

David Raymond Koos

Chairman, Chief Executive Officer, President, Acting Chief Financial Officer, Secretary & Treasurer

Employees

1

Country

US

Sector

Healthcare

Website

regenbiopharmainc.com

Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
0.0%
Institutional
(0)
0.0%
Insiderⓘ
(0)
0.0%
5%+ Owners
(0)
100.0%
Unattributed (incl. retail)ⓘ
Unattributed (incl. retail)100.0%
Sources: O/S: 1.7B · as of 12 Aug 2026 · SEC cover page
52-Week Range
$0.0001$0.0097
$0.0001(0th percentile)
Volume
Average Daily Volume3.27M
5.50K today vs 3.27M avg(-100%)

30d Avg

3.27M

60d Avg

4.85M

90d Avg

8.36M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...